Luteolin decreases the pathogenicity of Aeromonas hydrophila via inhibiting the activity of aerolysin

文献类型： 外文期刊

第一作者： Dong, Jing

作者： Dong, Jing;Zhang, Lushan;Liu, Yongtao;Xu, Ning;Zhou, Shun;Yang, Yibin;Yang, Qiuhong;Ai, Xiaohui;Dong, Jing;Liu, Yongtao;Xu, Ning;Zhou, Shun;Yang, Yibin;Yang, Qiuhong;Ai, Xiaohui

作者机构：

关键词： Aeromonas hydrophila; aerolysin; luteolin; anti-virulence; molecular dynamics

期刊名称：VIRULENCE （ 影响因子：5.882； 五年影响因子：6.489 ）

ISSN： 2150-5594

年卷期： 2021 年 12 卷 1 期

页码：

收录情况： SCI

摘要： Aeromonas hydrophila (A. hydrophila) can cause a number of diseases in both human and animals. A. hydrophila-related infections in aquaculture cause severe economic losses every year throughout the world. The emergence of antibiotic resistance that is due to the abuse of antibiotics has limited the application of antibiotics. Thus, novel approaches are needed to combat with treatment failure of antibiotics caused by resistant bacterial strains. Aerolysin plays a critical role in the pathogenesis of A. hydrophila and has been considered as a novel target for developing drugs based on anti-virulence strategies. Here, we reported that luteolin, a natural product with no anti-A. hydrophila activity, could reduce aerolysin-induced hemolysis by inhibiting aerolysin activity. The binding mode was simulated by molecular docking and dynamics simulation. Then the main binding sites were confirmed by fluorescence quenching assays. We found that luteolin could hindered the formation of functional heptamer of aerolysin according to the results of the oligomerization assay. Moreover, luteolin could protect A549 cells from aerolysin mediated cell death and increase the survival rate of A. hydrophila-infected channel catfish. These findings suggest a novel approach to developing drugs fighting against A. hydrophila, and luteolin can be a promising drug candidate for treatment of A. hydrophila-associated infections.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序